![LIVE Keynote presentation: Facilitating the development of individualized therapies](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F7a3d450a040d40efbc7bda07214427f2.png&q=0.8&m=fit&h=720)
![](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F7a3d450a040d40efbc7bda07214427f2.png&q=0.8&m=crop&h=720)
LIVE Keynote presentation: Facilitating the development of individualized therapies
Monday, March 29, 2021 2:00 PM to 2:20 PM · 20 min. (Africa/Abidjan)
Immunotherapy
Keynotes: Immunotherapy
Presentation
Information
- Defining the need for individualized therapies
- Current constraints to the development of individualized therapies and potential solutions
- Regulatory issues related to the development of individualized therapies
Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), FDA